Somaxon Pharmaceuticals, Inc.
Overview
Somaxon Pharmaceuticals, Inc. was a specialty pharmaceutical company focused on the in-licensing, development, and commercialization of proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system. The company was primarily known for its insomnia drug Silenor.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Somaxon Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Somaxon Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.